A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.
about
A Non-integrating Lentiviral Approach Overcomes Cas9-Induced Immune Rejection to Establish an Immunocompetent Metastatic Renal Cancer Model.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@en
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@nl
type
label
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@en
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@nl
prefLabel
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@en
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model.
@nl
P2093
P2860
P1476
A Non-integrating Lentiviral A ...... Metastatic Renal Cancer Model
@en
P2093
Allison C Sharrow
Beatrice S Knudsen
Jesse Novak
Kip Hermann
Maani Archang
Prateek Khanna
Rupal S Bhatt
Sabina Signoretti
P2860
P304
P356
10.1016/J.OMTM.2018.02.009
P50
P577
2018-02-23T00:00:00Z